Page last updated: 2024-11-07

vinylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

vinylglycine: irreversible inhibitor of aspartate aminotransferase; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-vinylglycine : A non-proteinogenic L-alpha-amino acid with a structure in which a vinyl group is bonded to the alpha-carbon of glycine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID156126
CHEBI ID43858
SCHEMBL ID278090
MeSH IDM0049111

Synonyms (21)

Synonym
l-vinylglycine
(2s)-2-amino-3-butenoic acid
DB03214
vinylglycine
(2s)-2-aminobut-3-enoic acid
70982-53-5
AKOS006238077
3-butenoic acid, 2-amino-, (2s)-
(s)-2-aminobut-3-enoic acid
SCHEMBL278090
AC-22586
l-vinylglycine (h-l-gly(vinyl)-oh)
mfcd00057844
CHEBI:43858
(2s)-2-amino-3-butenoic acid; (2s)-2-aminobut-3-enoic acid
(s)-2-amino-but-3-enoic acid
F31266
Q27094142
(s)-2-aminobut-3-enoicacid
DTXSID901025432
CS-0012700
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitorAn EC 4.4.1.* (C-S lyase) inhibitor that interferes with the action of 1-aminocyclopropane-1-carboxylate synthase (EC 4.4.1.14).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
glycine derivativeA proteinogenic amino acid derivative resulting from reaction of glycine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
L-alpha-amino acid zwitterionZwitterionic form of an L-alpha-amino acid having an anionic carboxy group and a protonated amino group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
11p11.2 copy number variation syndrome216

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (34.38)18.7374
1990's4 (12.50)18.2507
2000's12 (37.50)29.6817
2010's5 (15.63)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]